| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/05/2006 | EP1675878A2 Ldl receptor class a and egf domain monomers and multimers |
| 07/05/2006 | EP1436404A4 Engineered templates and their use in single primer amplification |
| 07/05/2006 | EP1313848B1 Yeast transformant producing recombinant human parathyroid hormone and method for producing the hormone |
| 07/05/2006 | EP1161250B9 Immunostimulant bacterial membrane fractions in cancer treatment |
| 07/05/2006 | EP1141298B1 Il-1 zeta, il-1 zeta splice variants and xrec2 dnas and polypeptides |
| 07/05/2006 | EP1112496B1 Diagnostic method for detecting disturbances of the pancreas |
| 07/05/2006 | EP1105485B1 Human il-1 epsilon dna and polypeptides |
| 07/05/2006 | EP1102838B1 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 07/05/2006 | EP0923740B1 Methods and compositions for the detection of cervical cancer |
| 07/05/2006 | EP0879289B1 Human dnase resistant to actin inhibition |
| 07/05/2006 | EP0778889B1 Recombinant adenovirus comprising a chimeric penton base protein |
| 07/05/2006 | EP0733109B9 Bmp-12, bmp-13 and tendon-inducing compositions thereof |
| 07/05/2006 | EP0721506B1 Bacterial exported proteins and acellular vaccines based thereon |
| 07/05/2006 | EP0702725B1 Method for recombinant production of biologically active polypeptides |
| 07/05/2006 | CN1798850A Drug |
| 07/05/2006 | CN1798848A Methods for producing biological substances in enzyme-deficient mutants of aspergillus niger |
| 07/05/2006 | CN1798838A Inhibitor proteins of a protease and use thereof |
| 07/05/2006 | CN1798837A Thioredoxin modification |
| 07/05/2006 | CN1798836A Methods for preventing gluconoylation of proteins |
| 07/05/2006 | CN1798834A Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stem cell, human monoclon |
| 07/05/2006 | CN1798766A Humanized antibodies that recognize beta amyloid peptide |
| 07/05/2006 | CN1798577A Method of inducing differentiation and proliferating regulatory t cell by anti-CD52 antibody and medicinal composition therefor |
| 07/05/2006 | CN1796558A Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 07/05/2006 | CN1796554A DNA fragment to promote translation reaction and method for cell-free protein synthesis system using the same |
| 07/05/2006 | CN1796541A Method for producing cyclodextrin glucose based transferase and dedicated strain |
| 07/05/2006 | CN1796408A Secretion protein, coding sequence and application |
| 07/05/2006 | CN1262663C Expression vector using for animal cell |
| 07/05/2006 | CN1262658C Recombined expression vector of restraining multiplication of leukemia cell |
| 07/05/2006 | CN1262657C Method for producing human leukemia inhibitory factor using transgenic plant |
| 07/05/2006 | CN1262650C Tissue cement proteins from rhipicephalus appendiculatus |
| 07/05/2006 | CN1262647C Production of oligomeric xylose and special immobilized xylanase therefor |
| 07/05/2006 | CN1262644C Nitrile hydratase and its coding gene and use |
| 07/05/2006 | CN1262643C Monocolone antibody, encoding gene, its uses and hybrid nodule cell line for cecreting same |
| 07/05/2006 | CN1262641C High-yield engineering bacterium of nicomycin X component and its application |
| 07/05/2006 | CN1262639C Novel host cells and method of producing proteins |
| 07/05/2006 | CN1262566C Low oxygen affinity mutant hemoglobins |
| 07/05/2006 | CN1262565C Recombinant fusion protein for diagnosis of tsutsugamushi disease |
| 07/05/2006 | CN1262562C HLA-A2 restraint tumor antigen peptide originating in SART-1 |
| 07/04/2006 | US7071373 introducing cultures of pluripotent cells into embryos having genetic complement comprising nucleotide sequence that code proteins; genetic engineering; xenografts |
| 07/04/2006 | US7071323 Anxiolytic agents; psychological disorders; insertion of genetic vector into nucleic acids, transcription |
| 07/04/2006 | US7071321 Identifying a BASB033 polypeptide or an antibody that is immunospecific for such polypeptide, present with in a biological sample form the animal suspected having meningococcus induced infections and meningitis |
| 07/04/2006 | US7071316 Human Akt-3 |
| 07/04/2006 | US7071312 Epidermal differentiation factor |
| 07/04/2006 | US7071311 Antibodies having specificity for 2′-C-allyl nucleic acids |
| 07/04/2006 | US7071310 Antibody against the human toll- like receptor 2 (tlr2) and uses thereof |
| 07/04/2006 | US7071307 Nucleic acids and proteins with thioredoxin reductase activity |
| 07/04/2006 | US7071306 AMPA-binding human GluR4 receptors |
| 07/04/2006 | US7071160 Integrin binding polipeptide for diagnosis, prevention and treatment of renal failure, thrombosis, osteoporosis, cancers and diabetes |
| 07/04/2006 | US7071159 Solubility forms; skin disorders, rheumatic disorders, antidiabetic agents |
| 07/04/2006 | US7070992 Improved efficiency of gene expression |
| 07/04/2006 | US7070989 Genetic engineered plasmid vectors; antibiotic resistance; anticancer agents |
| 07/04/2006 | US7070977 Human serine protease D-G polypeptide |
| 07/04/2006 | US7070975 Comprises disintegrin enzymatic polypeptide for use in the identification of modulators for treatment of bone, vision and respiratory system disorders; enzyme inhibitors |
| 07/04/2006 | US7070971 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 07/04/2006 | US7070970 Nutrients, animal feeds, cosmetics; elongation of polyunsaturated fatty acid |
| 07/04/2006 | US7070960 Forming monoclonal antibodies; hybridomas culture; variations in concentration of solute; monitoring gene expression |
| 07/04/2006 | US7070958 Methods of making pro-urokinase mutants |
| 07/04/2006 | US7070957 STARS—a muscle-specific actin-binding protein |
| 07/04/2006 | US7070956 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
| 07/04/2006 | US7070955 Comprises nucleotide sequences coding membrane proteins for diagnosing, preventing and treating inflammatory, cell proliferative and autoimmune diseases |
| 07/04/2006 | US7070953 foods, feeds, cosmetics; fish extarct; agreegable taste, flavor, odor; incubating aqueous slurry; extraction |
| 07/04/2006 | US7070945 Process for determining the presence of monomeric brain associated human glutamine synthetase in patients exhibiting mild cognitive impairment |
| 07/04/2006 | US7070928 Evolving new molecular function |
| 07/04/2006 | US7070794 is a mixture having an amino acid, peptide, and/or protein fragment molecular weight range of 200 880,000 daltons and having high simmondsin concentration |
| 07/04/2006 | US7070792 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 07/04/2006 | US7070791 Comprises genetically engineered bacteriophage polymerase for detection and treatment of microorganismal infections |
| 07/04/2006 | US7070779 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis, and bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions |
| 07/04/2006 | CA2396674C Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein |
| 07/04/2006 | CA2123069C Immunoassay for analytes in samples using alkylating agents |
| 06/29/2006 | WO2006069290A2 Enzymes for starch processing |
| 06/29/2006 | WO2006069289A2 Polypeptides having glucoamylase activity and polynucleotides encoding same |
| 06/29/2006 | WO2006068148A1 Recombinant microorganism |
| 06/29/2006 | WO2006067913A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited |
| 06/29/2006 | WO2006067847A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited |
| 06/29/2006 | WO2006067147A1 Process to improve activity of mannoprotein as wine stabiliser |
| 06/29/2006 | WO2006067145A1 New mannoprotein with full solubility in wine and its application in the stabilisation of wine |
| 06/29/2006 | WO2006066595A2 Recombinant production of serum albumin |
| 06/29/2006 | WO2006066416A1 Method for biotransformation of the clyclosporin compound isa247 |
| 06/29/2006 | WO2006023420A3 Integrin antagonists with enhanced antibody dependent cell-mediated cytotoxicity activity |
| 06/29/2006 | WO2005019242A8 Recombinant expression of the hag1 antimicrobial peptide: use as fusion partner for the expression of alpha helical antimicrobial peptides |
| 06/29/2006 | WO2003093444A3 Transporters and ion channels |
| 06/29/2006 | WO2003091413A3 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same |
| 06/29/2006 | US20060143738 Proteases and methods for producing them |
| 06/29/2006 | US20060142558 Novel proteins and their uses |
| 06/29/2006 | US20060142547 Anktm1, a cold-activated trp-like channel expressed in nociceptive neurons |
| 06/29/2006 | US20060142546 Immunogenic muc1 glycopeptides |
| 06/29/2006 | US20060142220 Protein modification |
| 06/29/2006 | US20060142199 CD-44 like protein |
| 06/29/2006 | US20060142196 Soluble GDNFR (Glial-cell Derived Neurotrophic Factor) that retains both ligand binding, and receptor signaling function (via Ret receptor tyrosine kinase) used to impart, restore, or enhance GDNFR alpha -ligand (preferably GDNF) responsiveness to cells; kidney diseases |
| 06/29/2006 | US20060142189 polypeptides derived from the ankyrin binding domain of the L1-cellular adhesion molecules (L1-CAM), used in the treatment of strokes,neurodegenerative disease, spinal cord and brain injuries |
| 06/29/2006 | US20060142188 Monkey alpha-7 nicotinic acetylcholine receptor and methods of use thereof |
| 06/29/2006 | US20060142171 Novel alkaline protease |
| 06/29/2006 | US20060141603 Methods and compositions for selectively enriching microbes |
| 06/29/2006 | US20060141583 Strain of Streptomyces in which a polyketide synthase gene encoding a polypeptide having the amino acid sequence of SEQ ID NO:14 within an elaiophylin gene cluster is disrupted by the recombinant substitution |
| 06/29/2006 | US20060141582 Anti-IL-22RA antibodies and binding partners and methods of using in inflammation |
| 06/29/2006 | US20060141581 IL-7 variants with reduced immunogenicity |
| 06/29/2006 | US20060141580 Encoding protein with immunomodulatory activity, antiviral activity, and antitumor activity; treating any Type 1 interferon treatable disease including cancer; determining if a patient will respond to interferon treatment; transgenic animals |
| 06/29/2006 | US20060141579 Cytokine zcytor17 ligand polynucleotides |
| 06/29/2006 | US20060141578 effective protein synthesis by regulating the expression of a protein in a host cell; preparing transgenic cells and inducing expression of heterologous sequences; tissue engineering and in vitro translation; efficiency and convenience |
| 06/29/2006 | US20060141577 Selection of host cells expressing protein at high levels |